BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hara T, Kouno J, Nakamura K, Kusaka M, Yamaoka M. Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells. Prostate 2005;65:268-75. [DOI: 10.1002/pros.20282] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Yamamoto S, Matsunaga N, Hitaka T, Yamada M, Hara T, Miyazaki J, Santou T, Kusaka M, Yamaoka M, Kanzaki N, Furuya S, Tasaka A, Hamamura K, Ito M. Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists. Bioorganic & Medicinal Chemistry 2012;20:422-34. [DOI: 10.1016/j.bmc.2011.10.067] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
2 Cipponi A, Thomas DM. Stress-induced cellular adaptive strategies: ancient evolutionarily conserved programs as new anticancer therapeutic targets. Bioessays 2014;36:552-60. [PMID: 24706439 DOI: 10.1002/bies.201300170] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
3 Cisneros L, Bussey KJ, Orr AJ, Miočević M, Lineweaver CH, Davies P. Ancient genes establish stress-induced mutation as a hallmark of cancer. PLoS One 2017;12:e0176258. [PMID: 28441401 DOI: 10.1371/journal.pone.0176258] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
4 Chandrasekar T, Yang JC, Gao AC, Evans CP. Mechanisms of resistance in castration-resistant prostate cancer (CRPC). Transl Androl Urol 2015;4:365-80. [PMID: 26814148 DOI: 10.3978/j.issn.2223-4683.2015.05.02] [Cited by in F6Publishing: 115] [Reference Citation Analysis]
5 Shafi AA, Yen AE, Weigel NL. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Pharmacol Ther. 2013;140:223-238. [PMID: 23859952 DOI: 10.1016/j.pharmthera.2013.07.003] [Cited by in Crossref: 142] [Cited by in F6Publishing: 143] [Article Influence: 15.8] [Reference Citation Analysis]
6 Bordonaro M. Hypothesis: Cancer Is a Disease of Evolved Trade-Offs Between Neoplastic Virulence and Transmission. J Cancer 2018;9:1707-24. [PMID: 29805696 DOI: 10.7150/jca.24679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Bordonaro M. Quantum biology and human carcinogenesis. Biosystems 2019;178:16-24. [DOI: 10.1016/j.biosystems.2019.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 van der Poel HG. Molecular markers in the diagnosis of prostate cancer. Crit Rev Oncol Hematol 2007;61:104-39. [PMID: 16945550 DOI: 10.1016/j.critrevonc.2006.07.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
9 Quinto-Alemany D, Canerina-Amaro A, Hernández-Abad LG, Machín F, Romesberg FE, Gil-Lamaignere C. Yeasts acquire resistance secondary to antifungal drug treatment by adaptive mutagenesis. PLoS One 2012;7:e42279. [PMID: 22860105 DOI: 10.1371/journal.pone.0042279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
10 Piper BJ, Alinea AA, Wroblewski JR, Graham SM, Chung DY, McCutcheon LRM, Birkett MA, Kheloussi SS, Shah VM, Szarek JL, Zalim QK, Arnott JA, McLaughlin WA, Lucchesi PA, Miller KA, Waite GN, Bordonaro M. A Quantitative and Narrative Evaluation of Goodman and Gilman's Pharmacological Basis of Therapeutics. Pharmacy (Basel) 2019;8:E1. [PMID: 31861770 DOI: 10.3390/pharmacy8010001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
11 Waltering KK, Urbanucci A, Visakorpi T. Androgen receptor (AR) aberrations in castration-resistant prostate cancer. Mol Cell Endocrinol 2012;360:38-43. [PMID: 22245783 DOI: 10.1016/j.mce.2011.12.019] [Cited by in Crossref: 116] [Cited by in F6Publishing: 97] [Article Influence: 11.6] [Reference Citation Analysis]
12 Yap TA, Smith AD, Ferraldeschi R, Al-lazikani B, Workman P, de Bono JS. Drug discovery in advanced prostate cancer: translating biology into therapy. Nat Rev Drug Discov 2016;15:699-718. [DOI: 10.1038/nrd.2016.120] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 10.8] [Reference Citation Analysis]
13 Bordonaro M, Chiaro CR, May T. Experimental design to evaluate directed adaptive mutation in Mammalian cells. JMIR Res Protoc 2014;3:e74. [PMID: 25491410 DOI: 10.2196/resprot.3860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Chandrasekar T, Yang JC, Gao AC, Evans CP. Targeting molecular resistance in castration-resistant prostate cancer. BMC Med 2015;13:206. [PMID: 26329698 DOI: 10.1186/s12916-015-0457-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
15 Bergerat JP, Céraline J. Pleiotropic functional properties of androgen receptor mutants in prostate cancer. Hum Mutat 2009;30:145-57. [PMID: 18800375 DOI: 10.1002/humu.20848] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
16 Jarzen J, Diamanduros A, Scarpinato KD. Mismatch repair proteins in recurrent prostate cancer. Adv Clin Chem 2013;60:65-84. [PMID: 23724741 DOI: 10.1016/b978-0-12-407681-5.00002-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res 2014;20:6570-81. [PMID: 25316813 DOI: 10.1158/1078-0432.CCR-14-1746] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 6.1] [Reference Citation Analysis]
18 Ramalingam S, Ramamurthy VP, Njar VCO. Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets. J Steroid Biochem Mol Biol 2017;166:16-27. [PMID: 27481707 DOI: 10.1016/j.jsbmb.2016.07.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
19 Hara T, Ushio K, Nishiwaki M, Kouno J, Araki H, Hikichi Y, Hattori M, Imai Y, Yamaoka M. A mutation in β-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line. Cell Biol Int 2010;34:177-84. [DOI: 10.1042/cbi20090030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
20 Ryu HY, Ahn SH, Hochstrasser M. SUMO and cellular adaptive mechanisms. Exp Mol Med 2020;52:931-9. [PMID: 32591648 DOI: 10.1038/s12276-020-0457-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Pybus C, Pedraza-Reyes M, Ross CA, Martin H, Ona K, Yasbin RE, Robleto E. Transcription-associated mutation in Bacillus subtilis cells under stress. J Bacteriol 2010;192:3321-8. [PMID: 20435731 DOI: 10.1128/JB.00354-10] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
22 Jentzmik F, Azoitei A, Zengerling F, Damjanoski I, Cronauer MV. Androgen receptor aberrations in the era of abiraterone and enzalutamide. World J Urol 2016;34:297-303. [PMID: 26100946 DOI: 10.1007/s00345-015-1624-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
23 Yu S, Jia L, Zhang Y, Wu D, Xu Z, Ng CF, To KK, Huang Y, Chan FL. Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation. Cancer Lett 2013;328:83-94. [PMID: 22995070 DOI: 10.1016/j.canlet.2012.09.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]